Adams Thomas Phd Insider Trades

Insider Trading History

Track insider trading activity for Adams Thomas Phd. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $741k 477,870 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$6.02k 755 shares
$7.98
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $741k 477,870 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.78k 223 shares
$7.98
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $741k 477,870 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.38M 173,145 shares
$7.98
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $741k 477,870 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.38M 298,320 shares
$7.98
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $741k 477,870 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.17k 272 shares
$7.98
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $741k 477,870 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.78k 223 shares
$7.98
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Holding Value $741k 477,870 shares
Last Trade
Jun 10, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$4.23k 530 shares
$7.98
$1.55
Hepion Pharmaceuticals
Hepion Pharmaceuticals HEPA
Director
Holding Value $18k 291,050 shares
Last Trade
May 18, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$330M 200,000 shares
$1,650.00
$0.06
Hepion Pharmaceuticals
Hepion Pharmaceuticals HEPA
Director
Holding Value $5.65k 91,050 shares
Last Trade
Aug 19, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$111M 30,000 shares
$3,700.00
$0.06
Cardiff Oncology
Cardiff Oncology CRDF
Executive Chairman
Holding Value $741k 477,870 shares
Last Trade
Jun 17, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$450k 173,145 shares
$2.60
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $29.3k 18,875 shares
Last Trade
May 14, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$20k 13,986 shares
$1.43
$1.55
Hepion Pharmaceuticals
Hepion Pharmaceuticals HEPA
Director
Holding Value $3.79k 61,051 shares
Last Trade
Apr 03, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$94.2M 60,000 shares
$1,570.00
$0.06
Hepion Pharmaceuticals
Hepion Pharmaceuticals HEPA
Director
Holding Value $65.2 1,051 shares
Last Trade
Jul 24, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.94M 970 shares
$3,030.00
$0.06
Cardiff Oncology
Cardiff Oncology CRDF
Chief Executive Officer
Holding Value $472k 304,725 shares
Last Trade
Jun 20, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$740k 298,230 shares
$2.48
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $724k 467,277 shares
Last Trade
Jan 23, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.17M 54,322 shares
$21.49
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $0 0 shares
Last Trade
Jan 02, 2018 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$366k 16,667 shares
$21.96
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $546k 351,959 shares
Last Trade
Jan 02, 2018 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$366k 16,667 shares
$21.96
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $640k 412,955 shares
Last Trade
Oct 04, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.9M 38,106 shares
$49.81
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $25.8k 16,667 shares
Last Trade
Sep 02, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$450k 8,806 shares
$51.12
$1.55
Cardiff Oncology
Cardiff Oncology CRDF
Director
Holding Value $520k 335,292 shares
Last Trade
Sep 02, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$450k 8,806 shares
$51.12
$1.55

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up